tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matt O'brien, 716 are a BUY (83.94%), 131 are a HOLD (15.36%), 6 are a SELL (0.7%).
Analyst Matt O'brien, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 61.85% that have a potential upside of 27.91% achieved within 184 days.
Matt O'brien’s has documented 1,776 price targets and ratings displayed on 62 stocks. The coverage is on Healthcare, Financial Services sectors.
Most recent stock forecast was given on CNMD, CONMED at 17-Mar-2026.
Analyst best performing recommendations are on OBIO (ORCHESTRA BIOMED HOLDINGS).
The best stock recommendation documented was for ZYXI (ZYNEX) at 7/15/2021. The price target of $13.64 was fulfilled within 1 day with a profit of $1.24 (10%) receiving and performance score of 100.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 02-Nov-2022
$388
$6.98 (1.83%)
$355
3 years 5 months 1 days ago
(02-Nov-2022)
2/5 (40%)
$14.49 (3.88%)
88
Hold Since 02-Nov-2022
$380
$-1.02 (-0.27%)
$235
3 years 5 months 1 days ago
(02-Nov-2022)
1/2 (50%)
$6.49 (1.74%)
36
Hold Since 01-Nov-2022
$380
$-1.02 (-0.27%)
$350
3 years 5 months 2 days ago
(01-Nov-2022)
24/41 (58.54%)
$2.18 (0.58%)
138
Buy Since 30-Jun-2021
$300
3 years 5 months 21 days ago
(13-Oct-2022)
1/3 (33.33%)
$57.23 (23.57%)
20
Sell Since 12-Feb-2020
$235
$-146.02 (-38.32%)
$275
3 years 8 months 19 days ago
(15-Jul-2022)
7/12 (58.33%)
$-33.23 (-12.39%)
161
Which stock is Matt O'brien is most bullish on?
Which stock is Matt O'brien is most reserved on?
What Year was the first public recommendation made by Matt O'brien?
